Soligenix (SNGX) Amortizatization of Intangibles (2015 - 2016)
Soligenix's (SNGX) quarterly Amortizatization of Intangibles came in at $1030.0 in Q2 2016, down 83.52% on a QoQ basis from $6251.0 in Q1 2016.
Soligenix (SNGX) Amortizatization of Intangibles (2015 - 2016) Analysis & Trends
Soligenix (SNGX) has 2 years of Amortizatization of Intangibles data on file, last reported at $1030.0 in Q2 2016.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $1030.0 in Q2 2016, while the trailing twelve-month figure through Dec 2016 was $7281.0 (changed N/A YoY) and the FY2016 annual result came in at $7281.0, down 31.62% from the prior year.
- Amortizatization of Intangibles fell to $1030.0 in Q2 2016, from $6251.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $6320.0 in Q4 2015 to a low of $1030.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | 28,610.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 1,030.00 |
| Jun 30, 2016 | 1,030.00 |
| Mar 31, 2016 | 6,251.00 |
| Mar 31, 2016 | 6,251.00 |
| Dec 31, 2015 | 6,320.00 |
| Dec 31, 2015 | 6,320.00 |